Drug Changes


Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.

To request Medicare Part D prescription drug coverage determinations (including tiering or formulary exception requests) please use the following form:



Votrient Tablet 200 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
PAZOPanib HCl Tablet 200 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 10 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 10 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 20 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 20 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 30 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 30 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 40 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 40 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 50 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 50 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 60 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 60 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 70 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 70 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Zulresso Solution 100 MG/20ML Intravenous


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Not a self-administered drug
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Citalopram Hydrobromide Tablet 10 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Citalopram Hydrobromide Tablet 20 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Citalopram Hydrobromide Tablet 40 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
FLUoxetine HCl Capsule 10 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
FLUoxetine HCl Capsule 20 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
FLUoxetine HCl Capsule 40 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Sertraline HCl Tablet 100 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Sertraline HCl Tablet 25 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Sertraline HCl Tablet 50 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Alphagan P Solution 0.1 % Ophthalmic


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Brimonidine Tartrate Solution 0.1 % Ophthalmic Tier 2 Ophthalmic Intraocular Pressure Lowering Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Ciprodex Suspension 0.3-0.1 % Otic


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Ciprofloxacin-Dexamethasone Suspension 0.3-0.1 % Otic Tier 2 Otic Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Condylox Gel 0.5 % External


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Podofilox Gel 0.5 % External Tier 4 Dermatological Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Livalo Tablet 1 MG Oral


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Pitavastatin Calcium Tablet 1 MG Oral Tier 2 QL Dyslipidemics, HMG CoA Reductase Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Livalo Tablet 2 MG Oral


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Pitavastatin Calcium Tablet 2 MG Oral Tier 2 QL Dyslipidemics, HMG CoA Reductase Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Livalo Tablet 4 MG Oral


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Pitavastatin Calcium Tablet 4 MG Oral Tier 2 QL Dyslipidemics, HMG CoA Reductase Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Korlym Tablet 300 MG Oral


Post Date:
4/24/2024
Effective Date:
5/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
miFEPRIStone Tablet 300 MG Oral Tier 5 PA Glycemic Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Rectiv Ointment 0.4 % Rectal


Post Date:
5/28/2024
Effective Date:
6/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Nitroglycerin Ointment 0.4 % Rectal Tier 4 Vasodilators, Direct-acting Arterial/ Venous
* Please reference your Evidence of Coverage for applicable cost-sharing.

Relyvrio Packet 3-1 GM Oral


Post Date:
5/28/2024
Effective Date:
6/1/2024
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Riluzole Tablet 50 MG Oral Tier 2 Central Nervous System, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sorine Tablet 80 MG Oral


Post Date:
5/28/2024
Effective Date:
6/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Sotalol HCl (AF) Tablet 80 MG Oral Tier 2 Antiarrhythmics
* Please reference your Evidence of Coverage for applicable cost-sharing.

Exkivity Capsule 40 MG Oral


Post Date:
7/29/2024
Effective Date:
8/1/2024
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tagrisso Tablet 40 MG Oral Tier 5 LA, PA, QL Molecular Target Inhibitors
Tagrisso Tablet 80 MG Oral Tier 5 LA, PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Zejula Capsule 100 MG Oral


Post Date:
8/29/2024
Effective Date:
9/1/2024
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Zejula Tablet 100 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Amcinonide Cream 0.1 % External


Post Date:
8/29/2024
Effective Date:
9/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Amcinonide Ointment 0.1 % External Tier 4 Dermatitis and Pruitus Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Endari Packet 5 GM Oral


Post Date:
9/26/2024
Effective Date:
10/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
L-Glutamine Packet 5 GM Oral Tier 5 QL, ST Genetic or Enzyme or Protein Disorder: Replacement, Modifiers, Treatment
* Please reference your Evidence of Coverage for applicable cost-sharing.

Isturisa Tablet 10 MG Oral


Post Date:
9/26/2024
Effective Date:
10/1/2024
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace and Part D No
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Isturisa Tablet 1 MG Oral Tier 5 PA, QL Hormonal Agents, Stimulant/ Replacement/ Modifying (Adrenal)
Isturisa Tablet 5 MG Oral Tier 5 PA, QL Hormonal Agents, Stimulant/ Replacement/ Modifying (Adrenal)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Lexiva Suspension 50 MG/ML Oral


Post Date:
9/26/2024
Effective Date:
10/1/2024
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Fosamprenavir Calcium Tablet 700 MG Oral Tier 5 Anti-HIV Agents, Protease Inhibitors (PI)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Zorbtive Solution Reconstituted 8.8 MG Subcutaneous


Post Date:
9/26/2024
Effective Date:
10/1/2024
Type of Change:
Drug removed
Reason Changed:
Drug discontinued from marketplace and Part D No
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Gattex KIT 5 MG Subcutaneous Tier 5 LA, PA Gastrointestinal Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Efavirenz Capsule 200 MG Oral


Post Date:
10/28/2024
Effective Date:
11/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Efavirenz Tablet 600 MG Oral Tier 4 Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
Efavirenz-lamiVUDine-Tenofovir Tablet 400-300-300 MG Oral Tier 2 Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Efavirenz Capsule 50 MG Oral


Post Date:
10/28/2024
Effective Date:
11/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Efavirenz Tablet 600 MG Oral Tier 4 Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
Efavirenz-lamiVUDine-Tenofovir Tablet 400-300-300 MG Oral Tier 2 Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sancuso Patch 3.1 MG/24HR Transdermal


Post Date:
10/28/2024
Effective Date:
11/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Granisetron HCl Tablet 1 MG Oral Tier 2 PA Emetogenic Therapy Adjuncts
* Please reference your Evidence of Coverage for applicable cost-sharing.

Oxbryta Tablet 500 MG Oral


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
L-Glutamine Packet 5 GM Oral Tier 5 QL, ST Genetic or Enzyme or Protein Disorder: Replacement, Modifiers, Treatment
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 100 MG Oral


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 100 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 140 MG Oral


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 140 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 20 MG Oral


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 20 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 50 MG Oral


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 50 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 70 MG Oral


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 70 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Sprycel Tablet 80 MG Oral


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Dasatinib Tablet 80 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Tazorac Cream 0.05 % External


Post Date:
12/1/2024
Effective Date:
12/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Tazarotene Cream 0.05 % External Tier 4 Acne and Rosacea Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.


There are currently no changes for 2025